Skip to content

Canceled by the investigator. Clinical application of large segment allogeneic bone in repairing bone defect after resection of malignant bone tumor

Clinical application of large segment allogeneic bone in repairing bone defect after resection of malignant bone tumor

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063742
Enrollment
Unknown
Registered
2022-09-15
Start date
2022-09-15
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant bone tumor

Interventions

None listed

Sponsors

Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 66 Years

Inclusion criteria

Inclusion criteria: Primary malignant bone tumors confirmed by histopathology, bone defects repaired with massive allografts, complete clinical data, and long-term follow-up > 24 months.

Exclusion criteria

Exclusion criteria: The exclusion criteria should not be the reverse range of the inclusion criteria, please fill in again

Design outcomes

Primary

MeasureTime frame
Healing time;

Countries

China

Contacts

Public ContactQing Liu

Xiangya Hospital of Central South University

liuqing_csu@csu.edu.cn+86 18207425349

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026